Tag: Corvallis, Oregon

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Corvallis, Oregon

Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT

Added to Collection on: 2025-07-02 14:45:58

Tags for this article:

Corvallis, Oregon
Sarepta Therapeutics
NASDAQ
Limited liability partnership
Pomerantz LLP
Sarepta Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Palantir Co-Founder Joe Lonsdale Wants A FDA Overhaul With Special Forces-Style AI ...

Added to Collection on: 2025-07-08 15:10:43

Tags for this article:

Biotechnology
Corvallis, Oregon
Sarepta Therapeutics
Applied genetics
Muscular dystrophy
Delandistrogene moxeparvovec
Gene therapy
Palantir Technologies
Duchenne muscular dystrophy
Priority review
United States

Click the tags to see associated articles and topics

View Article Details
Roche stops shipping Sarepta gene therapy in some countries outside US - BioPharma Dive

Added to Collection on: 2025-07-23 16:18:01

Tags for this article:

Biotechnology
Corvallis, Oregon
Sarepta Therapeutics
Delandistrogene moxeparvovec
Applied genetics
Gene therapy
Roche
Food and Drug Administration

Click the tags to see associated articles and topics

View Article Details
FDA probes death of patient on Sarepta's Elevidys, partner Roche says death unrelated to therapy

Added to Collection on: 2025-07-25 23:28:31

Tags for this article:

Biotechnology
Corvallis, Oregon
Sarepta Therapeutics
Delandistrogene moxeparvovec
Muscular dystrophy
Genetic engineering
Applied genetics
Duchenne muscular dystrophy
Gene therapy
Roche
Duchenne

Click the tags to see associated articles and topics

View Article Details
Sarepta Stock Slumps After EU Regulator Recommends Refusing Approval To Its ... - Stocktwits

Added to Collection on: 2025-07-26 20:21:13

Tags for this article:

Biotechnology
Corvallis, Oregon
Sarepta Therapeutics
Muscular dystrophy
Delandistrogene moxeparvovec
Applied genetics
Duchenne muscular dystrophy
Gene therapy
StockTwits
Duchenne
Dystrophy
Roche
United States

Click the tags to see associated articles and topics

View Article Details
FDA allows Sarepta to resume some Elevidys shipments - BioPharma Dive

Added to Collection on: 2025-07-29 09:38:40

Tags for this article:

Biotechnology
Muscular dystrophy
Corvallis, Oregon
Sarepta Therapeutics
Rare diseases
Delandistrogene moxeparvovec
Duchenne muscular dystrophy
Genetic engineering
Gene therapy
Duchenne

Click the tags to see associated articles and topics

View Article Details
Sarepta Shares Surge 10.46% on Record Q2 Revenue Despite Safety Scrutiny Trading ...

Added to Collection on: 2025-08-07 23:06:05

Tags for this article:

Biotechnology
Molecular biology
Corvallis, Oregon
Sarepta Therapeutics
Delandistrogene moxeparvovec
Applied genetics
Gene therapy
Duchenne muscular dystrophy
Roche
Small interfering RNA

Click the tags to see associated articles and topics

View Article Details
Elevidys sales weaken; Neumora gets into obesity - BioPharma Dive

Added to Collection on: 2025-08-09 01:11:47

Tags for this article:

Biotechnology
Novo Nordisk
Applied genetics
Corvallis, Oregon
Sarepta Therapeutics
Delandistrogene moxeparvovec
Gene therapy
Duchenne muscular dystrophy
Pfizer
Familial amyloid polyneuropathy

Click the tags to see associated articles and topics

View Article Details
Sarepta Therapeutics, Inc. (SRPT) Investors - Contact Levi & Korsinsky Before August 25, 2025

Added to Collection on: 2025-08-09 13:27:01

Tags for this article:

Lawsuits
Corvallis, Oregon
Sarepta Therapeutics
Delandistrogene moxeparvovec
Securities Class Action
Private Securities Litigation Reform Act
Class action
Esq.Ed Korsinsky
Sarepta Therapeutics Inc.
Levi & Korsinsky LLP

Click the tags to see associated articles and topics

View Article Details
Is Vor Bio Stock Soaring Too High? - StocksToTrade

Added to Collection on: 2025-08-13 16:42:50

Tags for this article:

Corvallis, Oregon
Sarepta Therapeutics

Click the tags to see associated articles and topics

View Article Details
Book a Demo